{"id":"https://openalex.org/W2979523220","doi":"https://doi.org/10.1158/2326-6066.cir-19-0228","title":"Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages","display_name":"Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages","alternate_titles":[],"publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W2979523220","doi":"https://doi.org/10.1158/2326-6066.cir-19-0228","mag":"2979523220","pmid":"https://pubmed.ncbi.nlm.nih.gov/31611243"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.cir-19-0228","doi":"https://doi.org/10.1158/2326-6066.cir-19-0228","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-19-0228","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2979523220"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018585640","display_name":"Emeric Limagne","orcid":"https://orcid.org/0000-0002-1098-8441","observed_orcids":["https://orcid.org/0000-0002-1098-8441"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210123635","display_name":"Genomic and Immunotherapy Medical Institute","ror":"https://ror.org/02cw59y30","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123635"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emeric Limagne","raw_affiliation_strings":["1University Bourgogne Franche-Comt\u00e9, Dijon, France","2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","3Genetic and Immunology Medical Institute, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"3Genetic and Immunology Medical Institute, Dijon, France","institution_ids":["https://openalex.org/I4210123635"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085250039","display_name":"Marion Thibaudin","orcid":"https://orcid.org/0000-0002-1046-5982","observed_orcids":["https://orcid.org/0000-0002-1046-5982"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210123635","display_name":"Genomic and Immunotherapy Medical Institute","ror":"https://ror.org/02cw59y30","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123635"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marion Thibaudin","raw_affiliation_strings":["1University Bourgogne Franche-Comt\u00e9, Dijon, France","2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","3Genetic and Immunology Medical Institute, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"3Genetic and Immunology Medical Institute, Dijon, France","institution_ids":["https://openalex.org/I4210123635"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077546174","display_name":"Lisa Nuttin","orcid":"https://orcid.org/0009-0002-2634-4787","observed_orcids":["https://orcid.org/0009-0002-2634-4787"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210123635","display_name":"Genomic and Immunotherapy Medical Institute","ror":"https://ror.org/02cw59y30","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123635"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa Nuttin","raw_affiliation_strings":["1University Bourgogne Franche-Comt\u00e9, Dijon, France","2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","3Genetic and Immunology Medical Institute, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"3Genetic and Immunology Medical Institute, Dijon, France","institution_ids":["https://openalex.org/I4210123635"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058254321","display_name":"Aodrenn Spill","orcid":"https://orcid.org/0000-0002-7769-9011","observed_orcids":["https://orcid.org/0000-0002-7769-9011"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210123635","display_name":"Genomic and Immunotherapy Medical Institute","ror":"https://ror.org/02cw59y30","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123635"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Aodrenn Spill","raw_affiliation_strings":["1University Bourgogne Franche-Comt\u00e9, Dijon, France","2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","3Genetic and Immunology Medical Institute, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"3Genetic and Immunology Medical Institute, Dijon, France","institution_ids":["https://openalex.org/I4210123635"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073674085","display_name":"Valentin D\u00e9rang\u00e8re","orcid":"https://orcid.org/0000-0002-6311-5628","observed_orcids":["https://orcid.org/0000-0002-6311-5628"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210123635","display_name":"Genomic and Immunotherapy Medical Institute","ror":"https://ror.org/02cw59y30","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123635"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Valentin Derang\u00e8re","raw_affiliation_strings":["1University Bourgogne Franche-Comt\u00e9, Dijon, France","2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","3Genetic and Immunology Medical Institute, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"3Genetic and Immunology Medical Institute, Dijon, France","institution_ids":["https://openalex.org/I4210123635"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016814827","display_name":"Jean-David Fumet","orcid":"https://orcid.org/0000-0002-9444-941X","observed_orcids":["https://orcid.org/0000-0002-9444-941X"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210123635","display_name":"Genomic and Immunotherapy Medical Institute","ror":"https://ror.org/02cw59y30","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123635"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-David Fumet","raw_affiliation_strings":["1University Bourgogne Franche-Comt\u00e9, Dijon, France","2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","3Genetic and Immunology Medical Institute, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"3Genetic and Immunology Medical Institute, Dijon, France","institution_ids":["https://openalex.org/I4210123635"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062974425","display_name":"Nadia Amellal","orcid":"https://orcid.org/0000-0002-6171-6729","observed_orcids":["https://orcid.org/0000-0002-6171-6729"]},"institutions":[{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nadia Amellal","raw_affiliation_strings":["4Center for Therapeutic Innovation, Oncology Servier, Suresnes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Center for Therapeutic Innovation, Oncology Servier, Suresnes, France","institution_ids":["https://openalex.org/I4210135308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091572641","display_name":"Elisa Peranzoni","orcid":"https://orcid.org/0000-0002-2077-2409","observed_orcids":["https://orcid.org/0000-0002-2077-2409"]},"institutions":[{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisa Peranzoni","raw_affiliation_strings":["4Center for Therapeutic Innovation, Oncology Servier, Suresnes, France"],"raw_orcid":"https://orcid.org/0000-0002-2077-2409","affiliations":[{"raw_affiliation_string":"4Center for Therapeutic Innovation, Oncology Servier, Suresnes, France","institution_ids":["https://openalex.org/I4210135308"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033349265","display_name":"Val\u00e9rie Cattan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210135308","display_name":"Servier (France)","ror":"https://ror.org/034e7c066","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210135308"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Val\u00e9rie Cattan","raw_affiliation_strings":["4Center for Therapeutic Innovation, Oncology Servier, Suresnes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Center for Therapeutic Innovation, Oncology Servier, Suresnes, France","institution_ids":["https://openalex.org/I4210135308"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043463827","display_name":"Fran\u00e7ois Ghiringhelli","orcid":"https://orcid.org/0000-0002-5465-8305","observed_orcids":["https://orcid.org/0000-0002-5465-8305"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]},{"id":"https://openalex.org/I4210123635","display_name":"Genomic and Immunotherapy Medical Institute","ror":"https://ror.org/02cw59y30","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210123635"]},{"id":"https://openalex.org/I4210139033","display_name":"Centre de recherche Translationnelle en M\u00e9decine mol\u00e9culaire","ror":"https://ror.org/04d70nb60","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I159885104","https://openalex.org/I2746051580","https://openalex.org/I4210117091","https://openalex.org/I4210135996","https://openalex.org/I4210139033","https://openalex.org/I4399657933","https://openalex.org/I4405253280"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fran\u00e7ois Ghiringhelli","raw_affiliation_strings":["1University Bourgogne Franche-Comt\u00e9, Dijon, France","2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","3Genetic and Immunology Medical Institute, Dijon, France","5Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","6Centre de Recherche INSERM LNC-UMR1231, Dijon, France","Genetic and Immunology Medical Institute, Dijon, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1University Bourgogne Franche-Comt\u00e9, Dijon, France","institution_ids":[]},{"raw_affiliation_string":"2Cancer Biology Transfer Platform, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"3Genetic and Immunology Medical Institute, Dijon, France","institution_ids":["https://openalex.org/I4210123635"]},{"raw_affiliation_string":"5Department of Medical Oncology, Centre Georges-Fran\u00e7ois Leclerc, Dijon, France","institution_ids":["https://openalex.org/I4210094685"]},{"raw_affiliation_string":"6Centre de Recherche INSERM LNC-UMR1231, Dijon, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210139033"]},{"raw_affiliation_string":"Genetic and Immunology Medical Institute, Dijon, France","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.9534,"has_fulltext":false,"cited_by_count":155,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97511098,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"7","issue":"12","first_page":"1958","last_page":"1969"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trifluridine-tipiracil","display_name":"trifluridine/tipiracil","score":0.9980000257492065},{"id":"https://openalex.org/keywords/oxaliplatin","display_name":"oxaliplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/immunogenic-cell-death","display_name":"immunogenic cell death","score":0.9620000123977661},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.8159999847412109},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.871999979019165},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.7390000224113464},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.8190000057220459},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.8859999775886536},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.7009999752044678},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9980000257492065}],"concepts":[{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.8697310090065002},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6244252324104309},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5958802700042725},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5955653786659241},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.592853307723999},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5142912268638611},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.4755763113498688},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4312751889228821},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.359254390001297},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3224540948867798},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21644064784049988},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.19019395112991333},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.18605491518974304},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13784965872764587},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000079527","descriptor_name":"Immunogenic Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008264","descriptor_name":"Macrophages","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014271","descriptor_name":"Trifluridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014271","descriptor_name":"Trifluridine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1158/2326-6066.cir-19-0228","doi":"https://doi.org/10.1158/2326-6066.cir-19-0228","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.cir-19-0228","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},{"id":"pmid:31611243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31611243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W242040007","https://openalex.org/W1592864174","https://openalex.org/W1837926236","https://openalex.org/W1977315768","https://openalex.org/W1980850901","https://openalex.org/W1993442154","https://openalex.org/W1994993231","https://openalex.org/W2016612145","https://openalex.org/W2025641756","https://openalex.org/W2058837304","https://openalex.org/W2060669212","https://openalex.org/W2079068389","https://openalex.org/W2084155879","https://openalex.org/W2093424661","https://openalex.org/W2103789431","https://openalex.org/W2121288523","https://openalex.org/W2130153302","https://openalex.org/W2141766149","https://openalex.org/W2164001237","https://openalex.org/W2166937531","https://openalex.org/W2168083201","https://openalex.org/W2210453860","https://openalex.org/W2252550602","https://openalex.org/W2339117281","https://openalex.org/W2578528809","https://openalex.org/W2739132742","https://openalex.org/W2788640168","https://openalex.org/W2788975052","https://openalex.org/W2789450032","https://openalex.org/W2789563811","https://openalex.org/W2796409747","https://openalex.org/W2797203065","https://openalex.org/W2801380511","https://openalex.org/W2809595917","https://openalex.org/W2890224843","https://openalex.org/W2891938639","https://openalex.org/W2897154408","https://openalex.org/W2907170157","https://openalex.org/W2913558101","https://openalex.org/W2977672253","https://openalex.org/W4406984318","https://openalex.org/W6715674537"],"related_works":["https://openalex.org/W2898510035","https://openalex.org/W2740474221","https://openalex.org/W2977672253","https://openalex.org/W4320039241","https://openalex.org/W2732860236","https://openalex.org/W3005160823","https://openalex.org/W3112557276","https://openalex.org/W3201015819","https://openalex.org/W2898505225","https://openalex.org/W2885483974"],"abstract_inverted_index":{"Trifluridine/tipiracil":[0],"(FTD/TPI)":[1],"is":[2],"a":[3,162,184],"new":[4],"antimetabolite":[5],"agent":[6],"used":[7],"to":[8,54,63,127,136,147,192],"treat":[9],"chemorefractory":[10],"metastatic":[11,203],"colorectal":[12,39,204],"cancer.":[13,205],"FTD/TPI":[14,50,80,139,148,167,178],"induced":[15,179],"immunogenic":[16],"cell":[17,30,41],"death":[18],"(ICD)":[19],"in":[20,22,35,100,170,181,200],"vitro":[21],"the":[23,59,68,152,156,187],"microsatellite-stable":[24],"(MSS)":[25],"CT26":[26],"mouse":[27],"colon":[28],"carcinoma":[29],"line,":[31],"as":[32,34],"well":[33],"various":[36],"human":[37],"MSS":[38],"cancer":[40],"lines":[42],"(SW620,":[43],"Caco-2,":[44],"and":[45,81,106,119,149,168,177,196],"Colo-320).":[46],"The":[47,173],"combination":[48,60,174],"of":[49,145,155,166,175,189],"with":[51,113,138,202],"oxaliplatin":[52,82,141,150,169,176],"synergized":[53],"promote":[55],"ICD.":[56],"In":[57,78],"vivo,":[58,182],"was":[61,110,134],"able":[62],"induce":[64],"ICD,":[65],"but":[66,93],"not":[67,84],"single":[69],"agents,":[70],"although":[71,132],"all":[72],"treatment":[73],"groups":[74],"showed":[75,161],"T-cell":[76,104,129],"dependency.":[77],"addition,":[79],"did":[83],"affect":[85],"regulatory":[86],"T":[87,124],"cells":[88,92,118,195],"or":[89,140],"myeloid-derived":[90],"suppressor":[91],"eliminated":[94],"type-2":[95],"tumor-associated":[96],"macrophages":[97],"(TAM2),":[98],"resulting":[99],"higher":[101],"cytotoxic":[102],"CD8+":[103,123],"infiltration":[105],"activation.":[107],"This":[108],"effect":[109],"concomitantly":[111],"associated":[112],"PD-L1":[114],"expression":[115],"on":[116,122],"tumor":[117],"PD-1":[120],"induction":[121],"cells,":[125],"leading":[126],"secondary":[128],"exhaustion.":[130],"Finally,":[131],"anti\u2013PD-1":[133,146],"unable":[135],"synergize":[137],"monotherapy,":[142],"concomitant":[143],"administration":[144],"enhanced":[151],"antitumor":[153],"efficacy":[154,199],"double":[157],"chemotherapy.":[158],"Our":[159],"study":[160],"novel":[163],"immunomodulatory":[164],"role":[165],"depleting":[171],"TAM2.":[172],"ICD":[180],"providing":[183],"rationale":[185],"for":[186],"use":[188],"these":[190],"drugs":[191],"eliminate":[193],"immunosuppressive":[194],"boost":[197],"checkpoint":[198],"patients":[201]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2979523220","counts_by_year":[{"year":2026,"cited_by_count":17},{"year":2025,"cited_by_count":19},{"year":2024,"cited_by_count":30},{"year":2023,"cited_by_count":32},{"year":2022,"cited_by_count":30},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2019-10-18T00:00:00"}
